These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


162 related items for PubMed ID: 2677063

  • 21. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship.
    Coryell W, Turner RD, Sherman A.
    J Clin Psychopharmacol; 1987 Jun; 7(3):138-42. PubMed ID: 3298326
    [Abstract] [Full Text] [Related]

  • 22. Vinpocetine therapy does not change imipramine pharmacokinetics in man.
    Hitzenberger G, Schmid R, Braun W, Grandt R.
    Int J Clin Pharmacol Ther Toxicol; 1990 Mar; 28(3):99-104. PubMed ID: 2318551
    [Abstract] [Full Text] [Related]

  • 23. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH, Weller EB, Weller RA.
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [Abstract] [Full Text] [Related]

  • 24. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS, Wells BG, Cold JA, Froemming JH, Self TH, Jabbour JT.
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [Abstract] [Full Text] [Related]

  • 25. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases.
    Devane CL, Wolin RE, Rovere RA, Panahon NC, Sutfin TA, Jusko WJ.
    J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359
    [Abstract] [Full Text] [Related]

  • 26. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I, Beresewicz M, Puzyński S, Kalinowski A.
    Psychiatr Pol; 1994 Apr; 28(1):27-38. PubMed ID: 8190817
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Imipramine and desipramine disposition in the elderly.
    Abernethy DR, Greenblatt DJ, Shader RI.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Two varieties of plasma imipramine curves in psychotic depressions and normal controls.
    Haydu GG, Dhrymiotis A, Quinn GP.
    Am J Psychiatry; 1967 Aug; 124(2):257-60. PubMed ID: 4951590
    [No Abstract] [Full Text] [Related]

  • 31. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
    Gerrits CJ, Burris H, Schellens JH, Eckardt JR, Planting AS, van der Burg ME, Rodriguez GI, Loos WJ, van Beurden V, Hudson I, Fields S, Von Hoff DD, Verweij J.
    Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
    [Abstract] [Full Text] [Related]

  • 32. A controlled double blind comparative study of single dose administration of imipramine pamoate and divided dose of imipramine hydrochloride in depressive illness.
    Khorana AB.
    Indian J Physiol Pharmacol; 1981 May; 25(4):331-8. PubMed ID: 7042559
    [Abstract] [Full Text] [Related]

  • 33. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD, Brunswick DJ, Potter L, Rickels K.
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [Abstract] [Full Text] [Related]

  • 34. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
    Murren J, Modiano M, Clairmont C, Lambert P, Savaraj N, Doyle T, Sznol M.
    Clin Cancer Res; 2003 Sep 15; 9(11):4092-100. PubMed ID: 14519631
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The pharmacodynamics of desipramine and desmethyldesipramine in rats.
    Argenti D, D'Mello AP.
    J Pharmacol Exp Ther; 1994 Aug 15; 270(2):512-9. PubMed ID: 7915311
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of satraplatin (JM216), an oral platinum (IV) complex under daily oral administration for 5 or 14 days.
    Vouillamoz-Lorenz S, Buclin T, Lejeune F, Bauer J, Leyvraz S, Decosterd LA.
    Anticancer Res; 2003 Aug 15; 23(3C):2757-65. PubMed ID: 12926110
    [Abstract] [Full Text] [Related]

  • 39. Fluoxetine-imipramine interaction.
    Leroi I, Walentynowicz MA.
    Can J Psychiatry; 1996 Jun 15; 41(5):318-9. PubMed ID: 8793156
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK, van den Broek WW, Mulder PG, Moleman P, Bruijn JA.
    J Clin Psychopharmacol; 2008 Apr 15; 28(2):166-70. PubMed ID: 18344726
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.